NCT00879541 - Study of a pd vWF/FVIII, Biostate®, in Subjects With Haemophilia A | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions

Hemophilia A

Interventions

BIOLOGICAL

Biostate® [SP]

Single bolus intravenous dose of 50 IU/kg

BIOLOGICAL

Biostate® [SP]

The dose is dependent on the reason for use and may consist of repeated bolus doses as required to manage haemophilia condition.

BIOLOGICAL

Biostate® [RP]

Single bolus intravenous dose of 50 IU/kg.

Trial Locations (14)

Study Site, Plovdiv

Study Site, Sofia

Study Site, Varna

Study Site, Skopje

Study Site, Bialystok

Study Site, Gdansk

Study Site, Krakow

Study Site, Lublin

Study Site, Poznan

Study Site, Warsaw

Study Site, Wroclaw

Study Site, Barnaul

Study Site, Kirov

Study Site, Moscow